Service advice and planning
39 results
Applied filters
Ex-vivo GMO gene therapy medicinal products
13 February 2026This document outlines key areas for focus of pharmacy expertise prior to an organisation implementing ex-vivo genetically modified organism (GMO) gene therapy.
Tissue engineered products
13 February 2026This document outlines key areas for focus of pharmaceutical expertise prior to an organisation implementing tissue engineered products.
Submitting iQAAPS Quality Indicators (QIs)
14 August 2025Guidance for Accountable Pharmacists on submission of quality indicators (QI) for NHS Section 10 aseptic preparation activities using the iQAAPS system.
Supply and administration of medicines by staff group (P to Z)
1 April 2026Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.
Individually labelled medicines in residential custodial settings
11 March 2025Advice on using individually labelled medicines rather than stock medication for residential custodial settings.
Preparing for audits and inspections of aseptic services
10 March 2025Careful planning ensures maximum benefit for both the auditee and auditor
Use of PGDs by trainee registered healthcare professionals
12 February 2026Advice on the use of Patient Group Directions by registered healthcare professionals who are undertaking training and/or competency assessment
Product design considerations for optimising ATMP implementation
11 February 2026This guidance provides advice for ATMP developers, highlighting implementation challenges faced by the NHS and suggesting design consideration to minimise them.
Understanding iQAAPS
6 November 2025An introduction to the iQAAPS system, with information on how to access the system, find training resources and support contacts
Risk assessing Investigational Medicinal Products (IMPs)
29 April 2026Sponsor pharmacy responsibilities when assessing the risk associated with CTIMPs.